Cost-Effectiveness in the Dabrafenib Routine together with Trametinib Weighed against Other Focused Therapies, Immunotherapy, along with Dacarbazine for the treatment Unresectable or Metastatic Melanoma Along with BRAFV600 Mutation in Colombia.